Physician profile
Anthony C Mccanta
NPI 1730277658
$33,930.32
in general payments reported to CMS, 2019-2025
16 companies · $5,225 in 2025
The $5,225 reported for 2025 was more than what 91% of Adult Congenital Heart Disease providers received nationally (typical 2025 total: $272).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $112 · 2021: $235 · 2022: $6,673 · 2023: $12K · 2024: $9,405 · 2025: $5,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Travel and Lodging: $4,223 · Food and Beverage: $2,818 · Education: $82.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,175.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Travel and Lodging | $4,223.03 |
| Food and Beverage | $2,818.30 |
| Education | $82.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,456.79 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan |
| Medical Device Business Services, INC. | $11,025.00 | 2023-2024 | Carto 3 |
| Altathera Pharmaceuticals LLC | $3,455.33 | 2025 | Sotalol Hydrochloride |
| Abbott Laboratories | $1,623.86 | 2020-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $1,467.98 | 2019-2024 | Carto 3, Soundstar, Smartablatetm System Rf Generator |
| Boston Scientific Corporation | $398.31 | 2019-2025 | Cds Broad Portfolio Offering, Emblem Mri S-Icd |
| Irhythm Technologies, INC. | $80.63 | 2024 | Zio Monitor, Zio Xt Patch |
| Cardiva Medical, INC. | $75.97 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Tolmar, INC. | $60.30 | 2024-2025 | Fensolvi |
| Neurocrine Biosciences, INC. | $57.25 | 2025 | |
| Kyowa Kirin, INC. | $49.74 | 2024 | Crysvita |
| Philips North America LLC | $48.90 | 2020 | |
| Medtronic Vascular, INC. | $39.44 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $32.85 | 2021 | |
| Ani Pharmaceuticals, INC. | $29.64 | 2024 | Purified Cortrophin Gel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $28.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mccanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.